EU Telematics PIM _
 

Common Repository

_

Home

_

Human eSubmission

_
Veterinary esubmission
_

eSubmission CMB

_
CMB Documents
_

Documentation

_

Systems:

_

Common Repository

_
CESP
_

eAF

_

CESSP

_
eASMF
_
ePMF
_

eSubmission Gateway & eSubmission Web Client

_

Delivery file UI

_

eSubmission Gateway

_

PAM submission form

_
PSUR Repository
_

Industry access

_
NCA access
_

eCTD

_

eCTD v4.0

_

EU Module 1

_

SPOR

_

eSignatures

_
_

 

The introduction of the Common Repository on 28th February 2014 has enabled all National Competent Authorities (NCAs) to search, browse and download Centralised Procedure eCTD submissions for human products. The use of the Common Repository for Human Centralised Procedure submissions is mandatory since July 2015 and all NCAs are now using the Common Repository as their only source of Centralised Procedure submissions in compliance with the HMA eSubmission Roadmap.

The Common Repository has been extended to include all human Referral submissions from 1st September 2017. The use of the Common Repository for human Referral submissions will become mandatory for all NCAs on 1st of December 2017. There should be no referral submissions directly to any NCAs from 1st of December 2017 as these will be considered to have been delivered to the NCAs.

The Marketing Authorisation Holders submit applications only once to the European Medicines Agency and there should be no further submissions of any CDs/DVDs or CESP submissions to any individual Member States as this will take place electronically between the European Medicines Agency and the National Competent Authorities. Submissions sent to EMA via eSubmission Gateway/Web Client will be considered delivered to all National Competent Authorities’ representatives and alternates. This applies to all types of Human Centralised Procedure eCTD submissions, including PMF submissions and ASMF submissions related to centrally authorised products submitted in eCTD format.

The introduction of Common Repository has significantly reduced the time required for receiving and validating incoming applications and ensures continuous and immediate access to up-to-date dossiers. It has also significantly reduced the number of submissions sent by the applicants/MAH thereby reducing time and costs related to submissions.

It is essential that applicants only use one method of submission to EMA (via eSubmission Gateway/Web Client) and do not submit duplicate submissions to any NCAs on a physical media (CD/DVD) or via CESP as these might cause a delay in the processing of the application. Please see the updated CAP Dossier Requirements document for details.

22-09-2017

Romania is now using the Common Repository to receive Referral submissions. Please do not send any Referral submissions (including CAPs and NAPs) to Croatia, Estonia, Finland, Norway, Latvia and Romania, as these types of submissions are now retrieved via the Common Repository.

15-09-2017

Croatia and Finland are also now using the Common Repository to receive Referral submissions. Please do not send any Referral submissions (including CAPs and NAPs) to Croatia, Estonia, Finland, Norway and Latvia, as these types of submissions are now retrieved via the Common Repository.

14-09-2017

Estonia and Norway are now using the Common Repository to receive Referral submissions. Please do not send any Referral submissions (including CAPs and NAPs) to Estonia, Norway and Latvia, as these types of submissions are now retrieved via the Common Repository.

01-09-2017

The Common Repository has been extended to contain all human Referral submissions. The use of the Common Repository for referral submissions will become mandatory for all NCAs after a transitional period. The date for the mandatory use for Referral submissions by all NCAs will be announced shortly. The MAHs are advised to review the Dossier Requirements for referral, NAP and ancillary medicinal substances in medical devices document.

Latvia is now using the Common Repository to receive Referral submissions, in addition to all CAP submissions, from 1 September 2017. Please do not send any Referral submissions (including CAPs and NAPs) to Latvia as these are now retrieved via the Common Repository.

The Common Repository will be extended to all veterinary submissions in the centralised procedure. The Statement of Intent is available here.

The introduction of the Common Repository on 28th February 2014 enabled all National Competent Authorities (NCAs) to search, browse and download centralised procedure eCTD submissions for human products.The use of the Common Repository for Human Centralised Procedure submissions is mandatory since July 2015 and all NCAs are using the Common Repository as their only source of Centralised Procedure submissions in compliance with the HMA eSubmission Roadmap.

The Marketing Authorisation Holders submit applications only once to the European Medicines Agency and there should be no further submissions of any CDs/DVDs or CESP submissions to any individual Member States as this will take place electronically between the European Medicines Agency and the National Competent Authorities. Submissions sent to EMA via eSubmission Gateway/Web Client will be considered delivered to all National Competent Authorities’ representatives and alternates. This applies to all types of Human Centralised Procedure eCTD submissions, including PMF submissions and ASMF submissions related to centrally authorised products submitted in eCTD format.

The introduction of Common Repository has significantly reduced the time required for receiving and validating incoming applications and ensures continuous and immediate access to up-to-date dossiers. It has also significantly reduced the number of submissions sent by the applicants/MAH thereby reducing time and costs related to submissions.

It is essential that applicants only use one method of submission to EMA (via eSubmission Gateway/Web Client) and do not submit duplicate submissions to any NCAs on a physical media (CD/DVD) or via CESP as these might cause a delay in the processing of the application. Please see the updated CAP Dossier Requirements document for details.

Relevant for NCAs only:

  • The acceptable usage policy defines a set of rules for the Common Repository users, which give direction how to use the CR system in an optimal way, leading to good system response times, high reliability and an efficient use of the available IT resources.
  • AEMPS has developed a tool to automatically download from the Common Repository via the API. The tool is available for other NCAs free-of-charge. More information can be found here. Please inform Jose Manuel Simarro from AEMPS (jsimarro@aemps.es) if you have downloaded the tool.
  • Telematics website: http://euteleproj.eudra.org/
  • Common Repository: https://web-cr.eudra.org/

For further information please see the updated Q&A document. (08.11.2016) Updated

Statements of Intent and announcements

Statement of Intent on the mandatory use of Common Repository for human Referral submissions (14.09.2017) New

Statement of Intent on the extension of the Common Repository for all Veterinary submissions in Centralised Procedure (25.11.2016)

Who to Contact

NCA User registration https://servicedesk.ema.europa.eu
Common Repository related technical issues https://servicedesk.ema.europa.eu

 

 

 

 

 

 

 

 


 

EMA
©1995-2017 European Medicines Agency | Disclaimer | For technical support, please visit the EMA Service Desk portal using your user credentials for a system hosted by EMA (except Eudravigilance). If you do not have an account or have forgotten your credentials, please click here